| 상품명칭 |
Buprofezin |
| 별명 |
Buprofenzin; 2-tert.-Butylimino-3-isopropyl-5-phenylperhydro-1,3,5-thiodiazin-4-one; 2-((1,1-Dimethylethyl)imino)tetrahydro-3-(1-methylethyl)-5-phenyl-4H-1,3,5-thiadiazin-4-one; 2-(tert-Butylimino)-3-isopropyl-5-phenylperhydro-1,3,5-thidiazin-4-one; Applaud; NNI 750; 2-tert-butylimino-3-isopropyl-5-phenyl-1,3,5-thiadiazinan-4-one; 2-[(1,1-dimethylethyl)imino]tetrahydro-3-(1-methylethyl)-5-phenyl-4H-1,3,5-thiadiazin-4-one; (2Z)-2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one; (2Z)-2-(tert-butylimino)-5-(4-hydroxyphenyl)-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one |
| 분자식 |
C16H23N3O2S |
| 분자량 |
321.4377 |
| InChI |
InChI=1/C16H23N3O2S/c1-11(2)19-14(17-16(3,4)5)22-10-18(15(19)21)12-6-8-13(20)9-7-12/h6-9,11,20H,10H2,1-5H3/b17-14- |
| cas번호 |
69327-76-0 |
| 분자 구조 |
|
| 밀도 |
1.19g/cm3 |
| 녹는 점 |
104-106℃ |
| 비등점 |
452.8°C at 760 mmHg |
| 굴절 지수 |
1.592 |
| 인화점 |
227.6°C |
| 물 용해도 |
0.9 mg/L at 20℃ |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
